BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33500624)

  • 1. PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
    Beck Enemark M; Monrad I; Madsen C; Lystlund Lauridsen K; Honoré B; Plesner TL; Hamilton-Dutoit SJ; d'Amore F; Ludvigsen M
    Onco Targets Ther; 2021; 14():481-489. PubMed ID: 33500624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients.
    Enemark MBH; Sørensen EF; Hybel TE; Andersen MD; Madsen C; Lauridsen KL; Honoré B; d'Amore F; Plesner TL; Hamilton-Dutoit SJ; Ludvigsen M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolytic biomarkers predict transformation in patients with follicular lymphoma.
    Monrad I; Madsen C; Lauridsen KL; Honoré B; Plesner TL; Hamilton-Dutoit S; d'Amore F; Ludvigsen M
    PLoS One; 2020; 15(5):e0233449. PubMed ID: 32442224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.
    Enemark MB; Hybel TE; Madsen C; Lauridsen KL; Honoré B; Plesner TL; Hamilton-Dutoit S; d'Amore F; Ludvigsen M
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
    Enemark MBH; Wolter K; Campbell AJ; Andersen MD; Sørensen EF; Hybel TE; Madsen C; Lauridsen KL; Plesner TL; Hamilton-Dutoit SJ; Honoré B; Ludvigsen M
    Blood Adv; 2023 Dec; 7(24):7418-7432. PubMed ID: 37824846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation.
    Li ZH; Zhang MY; Federico M; Civallero M; Manni M; Alonso-Alvarez S; Hou J; Huang HH
    Cancer; 2024 May; ():. PubMed ID: 38809573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of initial, interim and end-of-therapy
    Xie M; Wang L; Jiang Q; Luo X; Zhao X; Li X; Jin J; Ye X; Zhao K
    Cancer Cell Int; 2021 Jul; 21(1):394. PubMed ID: 34311728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
    Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
    PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
    Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E
    J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
    Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
    Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
    J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of diffuse large B-cell lymphoma transformed from primary duodenal follicular lymphoma.
    Miyata-Takata T; Takata K; Sato Y; Taniguchi K; Takahashi Y; Ohara N; Yoshino T
    Pathol Int; 2014 Oct; 64(10):527-32. PubMed ID: 25186289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
    Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
    J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
    Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
    Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, risk factors and outcome of histological transformation in follicular lymphoma.
    Conconi A; Ponzio C; Lobetti-Bodoni C; Motta M; Rancoita PM; Stathis A; Moccia AA; Mazzucchelli L; Bertoni F; Ghielmini M; Cavalli F; Zucca E
    Br J Haematol; 2012 Apr; 157(2):188-96. PubMed ID: 22348437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
    Alonso-Álvarez S; Manni M; Montoto S; Sarkozy C; Morschhauser F; Wondergem MJ; Guarini A; Magnano L; Alcoceba M; Chamuleau M; Galimberti S; Gomes da Silva M; Holte H; Zucca E; Lockmer S; Aurer I; Marcheselli L; Stepanishyna Y; Caballero Barrigón MD; Salles G; Federico M
    Eur J Cancer; 2021 Nov; 157():132-139. PubMed ID: 34508995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Bischin AM; Dorer R; Aboulafia DM
    Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel acquisitions on biology and management of transformed follicular lymphoma.
    Minoia C; Zucca E; Conconi A
    Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China.
    Gao F; Zhang T; Liu X; Qu Z; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Wang X; Zhang H
    Front Oncol; 2022; 12():863021. PubMed ID: 36185179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.